High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients()()

INTRODUCTION: The treatment of patients with cystic fibrosis involves the use of ototoxic drugs, mainly aminoglycoside antibiotics. Due to the use of these drugs, fibrocystic patients are at risk of developing hearing loss. OBJECTIVE: To evaluate the hearing of patients with cystic fibrosis by High...

Descripción completa

Detalles Bibliográficos
Autores principales: Geyer, Lucia Bencke, Menna Barreto, Sergio Saldanha, Weigert, Liese Loureiro, Teixeira, Adriane Ribeiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442703/
https://www.ncbi.nlm.nih.gov/pubmed/26480907
http://dx.doi.org/10.1016/j.bjorl.2015.08.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442703/
https://www.ncbi.nlm.nih.gov/pubmed/26480907
http://dx.doi.org/10.1016/j.bjorl.2015.08.011

Ejemplares similares